Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses
**Background:** Studies have shown that improvements in glycemic control are associated with avoidance or delayed onset of diabetes complications, improvements in health-related quality of life, and reductions in diabetes-related health care costs. Clinical practice guidelines recommend maintaining...
Saved in:
Main Authors: | John E. Schneider, Anjani Parikh, Ivana Stojanovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-02-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9783 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shiftwork and insulin resistance in professional drivers: exploring the association using non-insulin-based surrogate measures
by: Mirella Youssef Tawfik, et al.
Published: (2025-01-01) -
The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease
by: Claude Messier, et al.
Published: (2005-01-01) -
A Validated RP-HPLC Method for the Determination of Recombinant Human Insulin in Bulk and Pharmaceutical Dosage Form
by: B. A. Moussa, et al.
Published: (2010-01-01) -
Non-material expenses of trade enterprises
by: Lukić Radojko, et al.
Published: (2019-01-01) -
Association between non-insulin-based insulin resistance surrogate makers and Helicobacter pylori infection: a population-based study
by: Jiayu Qiu, et al.
Published: (2025-01-01)